VIATRIS INC. for VIATRIS INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 501 Fair Prescription Drug Competition Act, REMS (Risk Evaluation and Mitigation Strategies)
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD WHELAND | — |
Health Issues HCR
H.R. 573, Bill to prohibit authorized generics during period of exclusivity; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID RICE | — |
| RICHARD WHELAND | — |
Budget/Appropriations BUD
Approps/OGD funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD WHELAND | — |
Medicare/Medicaid MMM
PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD WHELAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.